F-star Therapeutics Current Cash

F-star Therapeutics (FSTX) currently reports a current cash of $36M as of September 2022. That compares with $71M in the prior-year period — down 49.9% year over year. Use the charts on this page to explore F-star Therapeutics's current cash history and peer comparisons.

F-star Therapeutics's current cash decreased from $71M to $36M — a 49.9% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

F-star Therapeutics reported $36M in current cash as of September 2022. That compares with $71M in the prior-year period — down 49.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $36M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for F-star Therapeutics, and consider following FSTX for alerts when major investors trade the stock.

F-star Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $36M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FSTX with unrelated industries.